Explore by Dosage Form
Explore by Category
Explore by Dosage Form
Explore by Category
Sirio Pharma Co., Ltd. (SIRIO), founded in 1993, was listed on the Shenzhen Stock Exchange in 2019 (stock code: 300791.SZ). After over 30 years of rapid growth, SIRIO has emerged as a globally recognized leading nutrition product solution provider, encompassing market insights, customized solutions, differentiated R&D, global production capabilities, industry-wide collaboration and marketing empowerment. SIRIO is committed to serving clients and consumers worldwide, operating Seven automated production bases and five R&D centers across the globe. Through strategic partnerships with leading domestic and international enterprises, the company has positioned itself as one of the most influential players in the industry.
1993
SIRIO was founded
Began pharmaceutical manufacturing
2000
Started to provide contract manufacturing services for food and dietary supplements
2002
Launched the export business for food and dietary supplements
2003
Obtained pharmaceutical GMP certification and food GMP certicification
2007
Opened a second facility at the Shantou production site
Commenced operations at our gummy and solid dosage production facility, expanding to multi-formulation production capabilities
2010
Achieved U.S. NPA-cGMP certification and became the first formulation enterprise in China to achieve this certification**According to CIC
Securing an internationally recognized validation of pharmaceutical‑grade quality standards
2012
Launched our first plant-based softgel production lineIntroduced liquid production lines
2013
Ranked first for six consecutive years in China's dietary supplements export market share**According to CIC
Launched our first plant-based softgel production line
Achieved Australia's TGA GMP certification
2015
Brand-new testing center was put into use, laying the foundation for CNAS accreditation and strengthening quality control throughout the entire supply chain.
2016
Acquired Ayanda GmbH (Germany), now is Sirio Pharma Germany
Obtained UL certification (USA)
2018
Ma’anshan Health Industry Park started operation and we commenced scale production of our gummy
2019
Listed on the Shenzhen Stock Exchange (300791.SZ)
2021
Initiated the model program for the digital transformation of the nutrition product solution industry
2022
Established a R&D Center in Shanghai
Launched the Ma’anshan smart warehouse
2023
Acquired Best Formulations LLC (USA) Zhuhai Bonded Factory was put into operation
Shantou Industrial Park received the national "Green Factory" certification
2024
Launched a new automated packaging line in Sirio Pharma Germany
Our standard for Ubidecarenone Chewable Gels was included in the United States Pharmacopeia, making us the first Chinese company to participate in and contribute to United States Pharmacopeia
Established a pet nutrition manufacturing facility, marking our entry into the pet nutrition sector
2025
Established SIRIO Institute on Ageing
Our Thailand Industrial Park commenced construction
Partnering worldwide to explore new frontiers in the nutraceutical industry
